News

January 8, 2026

Light Horse Therapeutics selected by BioSpace as one of the hottest new life sciences companies in the United States for 2026

We are excited to share that BioSpace has selected Light Horse Therapeutics as one of its 15 NextGen: Class of 2026 – top life...

November 10, 2025

Light Horse Therapeutics selected by the American Chemical Society as one of the 10 Start-ups to Watch

We are excited to share that Chemical & Engineering News has selected Light Horse Therapeutics as one of its 10 Start-Ups to Watch....

January 9, 2025

Light Horse Therapeutics Debuts With $62 Million Series A Financing

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by...

January 9, 2025

Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class therapeutics...